BARCLAYS PLC - ARCTURUS THERAPEUTICS HLDGS ownership

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 170 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q4 2023. The put-call ratio across all filers is 1.10 and the average weighting 0.0%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of ARCTURUS THERAPEUTICS HLDGS
ValueSharesWeighting
Q2 2024$4,712
+290.4%
193,501
+441.4%
0.00%
Q1 2024$1,207
-54.7%
35,744
-57.7%
0.00%
-100.0%
Q4 2023$2,664
-7.3%
84,509
-24.9%
0.00%
-50.0%
Q3 2023$2,873
+2.9%
112,467
+15.5%
0.00%0.0%
Q2 2023$2,792
+34.8%
97,355
+12.6%
0.00%
+100.0%
Q1 2023$2,071
+12.6%
86,433
-20.3%
0.00%0.0%
Q4 2022$1,839
-99.9%
108,496
-10.1%
0.00%
-50.0%
Q3 2022$1,790,000
+155.0%
120,743
+170.5%
0.00%
Q2 2022$702,000
+631.2%
44,637
+1146.8%
0.00%
Q1 2022$96,000
-94.9%
3,580
-93.0%
0.00%
Q4 2021$1,898,000
+248.9%
51,246
+349.6%
0.00%
Q3 2021$544,000
+365.0%
11,397
+231.6%
0.00%
Q2 2021$117,000
-91.7%
3,437
-89.9%
0.00%
-100.0%
Q1 2021$1,409,000
-57.1%
34,131
-55.0%
0.00%
-50.0%
Q4 2020$3,288,000
+786.3%
75,806
+775.0%
0.00%
Q3 2020$371,000
-74.9%
8,664
-72.6%
0.00%
-100.0%
Q2 2020$1,477,000
+4002.8%
31,638
+1083.2%
0.00%
Q1 2020$36,000
+800.0%
2,674
+664.0%
0.00%
Q4 2019$4,000
+300.0%
350
+386.1%
0.00%
Q3 2019$1,000720.00%
Other shareholders
ARCTURUS THERAPEUTICS HLDGS shareholders Q4 2023
NameSharesValueWeighting ↓
Portolan Capital Management 484,907$11,807,4850.97%
Nikko Asset Management Americas, Inc. 1,563,065$37,966,8490.44%
Diametric Capital, LP 32,765$797,8270.43%
ARK Investment Management 1,964,964$47,846,8710.42%
SummerHaven Investment Management, LLC 23,400$569,7900.38%
Quantedge Capital Pte Ltd 40,800$993,4800.36%
Granahan Investment Management 344,549$8,389,7680.34%
FEDERATED HERMES, INC. 4,694,060$114,300,3610.27%
Belmont Capital, LLC 40,000$974,0000.18%
Woodline Partners LP 754,023$18,360,4600.18%
View complete list of ARCTURUS THERAPEUTICS HLDGS shareholders